首页> 外文OA文献 >Rebeccamycin derivatives as dual DNA damaging agents and potent checkpoint kinase 1 inhibitors.
【2h】

Rebeccamycin derivatives as dual DNA damaging agents and potent checkpoint kinase 1 inhibitors.

机译:瑞贝卡霉素衍生物作为双重DNA破坏剂和有效的关卡激酶1抑制剂。

摘要

Rebeccamycin is an indolocarbazole class inhibitor of topoisomerase I. In the course of structure-activity relationship studies on rebeccamycin derivatives, we have synthesized analogues with the sugar moiety attached to either one or both indole nitrogens. Some analogues, especially those with substitutions at the 6' position of the carbohydrate moiety exhibit potent inhibitory activity toward Checkpoint kinase 1 (Chk1), a kinase that has a major role in the G2/M checkpoint in response to DNA damage. Some of these compounds retained a genotoxic activity either through intercalation into the DNA and/or by topoisomerase I-mediated DNA cleavage. We explored the structure-activity relationship between these compounds and their multiple targets. These rebeccamycin derivatives represent a novel class of potential antitumor agents that have a dual effect and might selectively induce the death of cancer cells.
机译:瑞贝卡霉素是吲哚并咔唑类拓扑异构酶I的抑制剂。在对瑞贝卡霉素衍生物进行构效关系研究的过程中,我们合成了具有与一个或两个吲哚氮原子相连的糖基的类似物。一些类似物,尤其是那些在碳水化合物部分6'位置被取代的类似物,表现出对Checkpoint激酶1(Chk1)的有效抑制活性,该激酶在响应DNA损伤的G2 / M检查点中起主要作用。这些化合物中的一些通过插入DNA中和/或通过拓扑异构酶I介导的DNA裂解而保留了遗传毒性。我们探索了这些化合物与其多个靶标之间的构效关系。这些瑞贝卡霉素衍生物代表一类新型的潜在抗肿瘤药,具有双重作用,并可能选择性诱导癌细胞死亡。

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号